Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Nasal Provocation on Breathing Style
NCT02146300Unknown
- Sponsor
- Oulu University Hospital
- Start
- Mar 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of birch pollen extract and xylometazoline in allergic rhinitis (AR), sponsored by Oulu University Hospital. Primary endpoint: Breathing style at 2 hours. Status: unknown.
02
Drugs
birch pollen extractxylometazoline
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02146300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02146300.